Nicolas Palaskas MD, FACCAssistant Professor, Cardiology, UT-MD Anderson Cancer Center, Houston, Texas
Dr. Palaskas received his medical degree from The University of Texas Health Science Center, San Antonio. His postgraduate training included Internal Medicine residency at Baylor College of Medicine, followed by a clinical fellowship in General Cardiovascular Disease at Baylor College of Medicine where he received advanced level III echocardiographic imaging training. He has American Board of Internal Medicine Certifications in Internal Medicine and Cardiovascular Disease. Immediately following training he joined the cardiology division at the MD Anderson Cancer Center and his research interests include immune checkpoint inhibitor cardiotoxicity, tyrosine kinase inhibitor induced hypertension, and using new echocardiography techniques and modalities for the early detection of cancer therapeutic related cardiac dysfunction. He is also involved in medical student, resident, and fellow education and training receiving awards for trainee education in each year of his faculty appointment at MD Anderson Cancer Center.
Recent Contributions to PracticeUpdate:
- Off-Label Use of DOACs vs Warfarin for Left Ventricular Thrombi
- Efficacy and Safety of NOACs in Patients With Atrial Fibrillation and Cancer
- Hypertension and Incident Cardiovascular Events Following Ibrutinib Initiation
- Anticoagulation of Cancer Patients With Non‐Valvular Atrial Fibrillation Receiving Chemotherapy